Join us for a dynamic, live webinar where two leading GI oncology experts will break down the latest advancements in biomarker-based, first-line treatment strategies for upper gastrointestinal (GI) cancers. Key highlights include: A whiteboard animation video illustrating mechanisms of action for novel therapies, including anti-CLDN18.2 and immuno-oncology combinations, Current guideline recommendations and emerging clinical data, Actionable strategies for personalizing treatment decisions in upper GI cancers. Don't miss this opportunity to elevate your clinical expertise and apply cutting-edge evidence to patient care!